EcoDrugPlus

Ensembl ID : ENSDLAG00005014737
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSDLAG00005018607
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSDLAG00005018637
Gene Symbol: -
Cross references: -
650 Possible Orthologues:

Ensembl ID : ENSDLAG00005019638
Gene Symbol: -
1 Cross references
191 Possible Orthologues:

Ensembl ID : ENSDLAG00005019662
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSDLAG00005019701
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSDLAG00005019813
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSDLAG00005020353
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSDLAG00005020485
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSDLAG00005020547
Gene Symbol: RPL13
1 Cross references
273 Possible Orthologues:

Ensembl ID : ENSDLAG00005021042
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSDLAG00005021531
Gene Symbol: -
Cross references: -
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).